HW
Hing C Wong
Chief Executive OfficerDirector10% Owner

Hing C Wong insider trades: HCW Biologics (HCWB) stock purchases

Chief Executive Officer, HCW Biologics Last trade Jul 29, 2026 16 Form 4 filings
$0
Sold, last 12 months
0 sales
$220K
Bought, last 12 months
2 buys
14
Open-market trades
since 2021
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Hing reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 29, 2026HCWB↑ Buy$60K
May 22, 2026HCWB↑ Buy$160K
May 16, 2025HCWB↑ Buy$60K
May 8, 2025HCWB↑ Buy$2.4M
Sep 14, 2023HCWB↑ Buy$4K
Jun 2, 2023HCWB↑ Buy$3K
May 31, 2023HCWB↑ Buy$8K
Sep 9, 2022HCWB↑ Buy$27K
Sep 7, 2022HCWB↑ Buy$26K
Jun 10, 2022HCWB↑ Buy$3K
Jun 9, 2022HCWB↑ Buy$7K
Aug 31, 2021HCWB↑ Buy$15K
Aug 30, 2021HCWB↑ Buy$71K
Jul 22, 2021HCWB↑ Buy$5.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other HCWB insiders

Open-market trades in the last 12 months

About Hing C Wong's insider trades

Hing C Wong is Chief Executive Officer at HCW Biologics (HCWB). Since Jul 22, 2021, Hing has reported 14 open-market purchases worth $7.9M and no sales on SEC Form 4. In the last 12 months: 2 buys ($220K).

Their filings also include other transactions (2 filings), grants and awards (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HCWB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.